AAAAAA

   
Results: 1-10 |
Results: 10
Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts
Authors: Newman, RA Yang, J Finlay, MRV Cabral, F Vourloumis, D Stephens, LC Troncoso, P Wu, XB Logothetis, CJ Nicolaou, KC Navone, NM
Citation: Ra. Newman et al., Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts, CANC CHEMOT, 48(4), 2001, pp. 319-326
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway
Authors: Yang, J Fizazi, K Peleg, S Sikes, CR Raymond, AK Jamal, N Hu, M Olive, M Martinez, LA Wood, CG Logothetis, CJ Karsenty, G Navone, NM
Citation: J. Yang et al., Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway, CANCER RES, 61(14), 2001, pp. 5652-5659
Glucocorticoids can promote androgen-independent growth of prostate cancercells through a mutated androgen receptor (vol 6, pg 703, 2000)
Authors: Zhao, XY Malloy, PJ Krishnan, AV Swami, S Navone, NM Peehl, DM Feldman, D
Citation: Xy. Zhao et al., Glucocorticoids can promote androgen-independent growth of prostate cancercells through a mutated androgen receptor (vol 6, pg 703, 2000), NAT MED, 6(8), 2000, pp. 939-939
Glucocorticoids can promote androgen-independent growth of prostate cancercells through a mutated androgen receptor
Authors: Zhao, XY Malloy, PJ Krishnan, AV Swami, S Navone, NM Peehl, DM Feldman, D
Citation: Xy. Zhao et al., Glucocorticoids can promote androgen-independent growth of prostate cancercells through a mutated androgen receptor, NAT MED, 6(6), 2000, pp. 703-706
TabBO: A model reflecting common molecular features of androgen-independent prostate cancer
Authors: Navone, NM Rodriguez-Vargas, MD Benedict, WF Troncoso, P McDonnell, TJ Zhou, JH Luthra, R Logothetis, CJ
Citation: Nm. Navone et al., TabBO: A model reflecting common molecular features of androgen-independent prostate cancer, CLIN CANC R, 6(3), 2000, pp. 1190-1197
1 alpha,25-dihydroxyvitamin D-3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms
Authors: Zhao, XY Peehl, DM Navone, NM Feldman, D
Citation: Xy. Zhao et al., 1 alpha,25-dihydroxyvitamin D-3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms, ENDOCRINOL, 141(7), 2000, pp. 2548-2556
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a
Authors: Zhao, XY Boyle, B Krishnan, AV Navone, NM Peehl, DM Feldman, D
Citation: Xy. Zhao et al., Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a, J UROL, 162(6), 1999, pp. 2192-2199
p53 mutations in prostate cancer bone metastases suggest that selected p53mutants in the primary site define foci with metastatic potential
Authors: Navone, NM Labate, ME Troncoso, P Pisters, LL Conti, CJ Von Eschenbach, AC Logothetis, CJ
Citation: Nm. Navone et al., p53 mutations in prostate cancer bone metastases suggest that selected p53mutants in the primary site define foci with metastatic potential, J UROL, 161(1), 1999, pp. 304-308
Molecular regulation and therapeutic implications of cell death in prostate cancer
Authors: McDonnell, TJ Bruckheimer, EM Gjertsen, BT Honda, T Navone, NM
Citation: Tj. Mcdonnell et al., Molecular regulation and therapeutic implications of cell death in prostate cancer, CANC DRUG, 5, 1999, pp. 241-255
Model systems of prostate cancer: Uses and limitations
Authors: Navone, NM Logothetis, CJ von Eschenbach, AC Troncoso, P
Citation: Nm. Navone et al., Model systems of prostate cancer: Uses and limitations, CANC METAST, 17(4), 1998, pp. 361-371
Risultati: 1-10 |